<bill session="116" type="s" number="3248" updated="2020-12-29T05:24:31Z">
  <state datetime="2020-12-17">PASS_OVER:SENATE</state>
  <status>
    <unknown datetime="2020-12-17"/>
  </status>
  <introduced datetime="2020-02-03"/>
  <titles>
    <title type="short" as="introduced">United States Anti-Doping Agency Reauthorization Act of 2020</title>
    <title type="short" as="reported to senate">United States Anti-Doping Agency Reauthorization Act of 2020</title>
    <title type="display">United States Anti-Doping Agency Reauthorization Act of 2020</title>
    <title type="official" as="introduced">A bill to reauthorize the United States Anti-Doping Agency, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M000934"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2020-02-03"/>
  </cosponsors>
  <actions>
    <action datetime="2020-02-03">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-02-03" state="REFERRED">
      <text>Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
    </action>
    <calendar datetime="2020-03-11" state="REPORTED">
      <text>Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment favorably.</text>
    </calendar>
    <action datetime="2020-11-17">
      <text>Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.</text>
    </action>
    <calendar datetime="2020-11-17" calendar="Senate Legislative" under="General Orders" number="594">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 594.</text>
    </calendar>
    <action datetime="2020-12-17">
      <text>Measure laid before Senate by unanimous consent.</text>
      <reference ref="CR S7641-7642" label="consideration"/>
    </action>
    <action datetime="2020-12-17">
      <text>The committee amendments withdrawn by Unanimous Consent.</text>
      <reference ref="CR S7641"/>
    </action>
    <vote how="by Unanimous Consent" type="vote" datetime="2020-12-17" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Passed Senate with an amendment by Unanimous Consent.</text>
      <reference ref="CR S7642" label="text of amendment in the nature of a substitute"/>
    </vote>
    <action datetime="2020-12-18">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2020-12-18T14:14:18-05:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2020-12-18T14:52:46-05:00">
      <text>Held at the desk.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSCM" name="Senate Commerce, Science, and Transportation" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="5373"/>
  </relatedbills>
  <subjects>
    <term name="Sports and recreation"/>
    <term name="Athletes"/>
    <term name="Congressional oversight"/>
    <term name="Criminal investigation, prosecution, interrogation"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="International law and treaties"/>
    <term name="Mammals"/>
    <term name="Olympic games"/>
    <term name="Veterinary medicine and animal diseases"/>
  </subjects>
  <amendments>
    <amendment number="s2715"/>
  </amendments>
  <summary date="2020-11-17T17:52:01Z" status="Reported to Senate">United States Anti-Doping Agency Reauthorization Act of 2020

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029.

The bill also directs (1) USADA to promote a positive youth sport experience by providing educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration&#160;to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

USADA must submit to Congress a report that (1) assesses its capacity to implement an equine anti-doping and medication control program; and (2) includes recommendations concerning best practices for the successful implementation of such a program in the United States and recommendations developed in consultation with the National Veterinary Services Laboratories regarding the appropriate technical standards and best practices.</summary>
  <committee-reports>
    <report>S. Rept. 116-301</report>
  </committee-reports>
</bill>
